08:54 AM EDT, 09/09/2025 (MT Newswires) -- MedX Health ( MDXHF ) said overnight Monday it is extending the closing date of its $2.5 million private placement by up to 30 days.

The company said it already received conditional acceptance from the TSX Venture Exchange, but closing for the full amount has been delayed. MedX first announced the offering on July 25.

The placement comprises up to 33,333,333 units at $0.075 each. Each unit includes one share and one-half of a warrant, with each whole warrant exercisable at $0.10 per share for one year.

Proceeds will be used to develop the company's SIAscopy on DermSecure telemedicine platform, support its launch into the occupational health market, and for general corporate purposes.

Separately, MedX said Tuesday it appointed Paul Matts as strategic advisor. Matts is a skin scientist, biochemist and educator who previously served as vice president of research and development at Procter & Gamble.

"His expertise will strengthen MedX's scientific foundation and help advance our goal of delivering accurate, trusted and widely-accessible skin cancer screening and the development of new skin assessment technologies for the health and beauty industry," MedX chief executive John Gevisser said.

MedX's share price fell 7.1% on Monday to $0.065 on the TSXV.